Haploidentical hematopoietic SCT for acquired severe aplastic anemia using post-transplant high-dose CY

Bone Marrow Transplantation

Volumn 50, Issue 1, 2015, Pages 155-156

  Gupta, N ^a   Choudhary, D ^a   Sharma, S K ^a   Khandelwal, V ^a   Dhamija, M ^a  

^a Department of Microbiology   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; CD34 ANTIGEN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; FLUDARABINE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS; THYMOCYTE ANTIBODY; IMMUNOSUPPRESSIVE AGENT;

ACUTE GRAFT VERSUS HOST DISEASE; ALLOIMMUNITY; APLASTIC ANEMIA; BLOOD CELL COUNT; CASE REPORT; CD4 CD8 RATIO; CHILD; CHRONIC GRAFT VERSUS HOST DISEASE; DISEASE SEVERITY; DRUG EFFICACY; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA MATCHING; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LETTER; LUNG ASPERGILLOSIS; NONMYELOABLATIVE CONDITIONING; POLYMERASE CHAIN REACTION; SCHOOL CHILD; TREATMENT RESPONSE; TUMOR VOLUME; WHOLE BODY RADIATION; ALLOGRAFT; ANEMIA, APLASTIC; GRAFT VS HOST DISEASE;

ALLOGRAFTS; ANEMIA, APLASTIC; CHILD; CYCLOSPORINE; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS;

EID: 84920639737     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2014.222     Document Type: Letter

References (10)

1. Guinan EC. Acquired aplastic anemia in childhood. Hematol Oncol Clin North Am 2009; 23: 171-191.
2. Bacigalupo A, Socie' G, Lanino E, Prete A, Locatelli F, Locasciulli A et al. Fludarabine, cyclophosphamide, antithymocyte globulin, with or without low dose total body irradiation, for alternative donor transplants, in acquired severe aplastic anemia: a retrospective study from the EBMT-SAA Working Party. Haematologica 2010; 95: 976-982.
3. Marsh JC, Kulasekararaj AG. Management of the refractory aplastic anemia patient: what are the options? Blood 2013; 122: 3561-3567.
4. Yoshimi A, Kojima S, Taniguchi S, Hara J, Matsui T, Takahashi Y, Azuma H et al. Unrelated cord blood transplantation for severe aplastic anemia. Biol Blood Marrow Transplant 2008; 14: 1057-1063.
5. Luznik L, O'Donnell PV, Symons HJ, Chen AR, Leffell MS, Zahurak M et al. HLA haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide. Biol Blood Marrow Transplant 2008; 14: 641-650.
6. Fuchs EJ. Human leukocyte antigen-haploidentical stem cell transplantation using T-cell-replete bone marrow grafts. Curr Opin Hematol 2012; 19: 440-447.
7. Bolaños-Meade J, Fuchs EJ, Luznik L, Lanzkron SM, Gamper CJ, Jones RJ et al. HLA haploidentical bone marrow transplantation with posttransplant cyclophosphamide expands the donor pool for patients with sickle cell disease. Blood 2012; 120: 4285-4291.
8. Raj K, Pagliuca A, Bradstock K, Noriega V, Potter V, Streetly M et al. Peripheral blood hematopoietic stem cells for transplantation of hematological diseases from related, haploidentical donors after reduced-intensity conditioning. Biol Blood Marrow Transplant 2014; 20: 890-895.
9. Ciceri F, Lupo-Stanghellini MT, Korthof ET. Haploidentical transplantation in patients with acquired aplastic anemia. Bone Marrow Transplant 2013; 48: 183-185.
10. Castagna L, Crocchiolo R, Furst S, Bramanti S, El Cheikh J, Sarina B et al. Bone marrow compared with peripheral blood stem cells for haploidentical transplantation with a nonmyeloablative conditioning regimen and posttransplantation cyclophosphamide. Biol Blood Marrow Transplant 2014; 20: 724-729.